{
    "title": "FOCUS-Biogen's secret campaign to bring its Alzheimer's drug back from the ashes",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7613207/FOCUS-Biogens-secret-campaign-bring-Alzheimers-drug-ashes.html",
    "date": "2019-10-25",
    "keywords": [
        "biogen",
        "trial",
        "drug",
        "company",
        "dose",
        "therapy",
        "analysis",
        "cohen",
        "decision",
        "march",
        "aducanumab",
        "approval",
        "fda",
        "treatment",
        "ban2401",
        "study",
        "meeting",
        "year",
        "december",
        "number",
        "chief",
        "interview",
        "nail",
        "coffin",
        "announcement",
        "cheung",
        "emerge",
        "month",
        "program",
        "shock",
        "week",
        "scrap",
        "heap",
        "nondisclosure",
        "group",
        "pool",
        "conclusion",
        "committee",
        "dark",
        "possibility",
        "feedback",
        "result",
        "tuesday",
        "reversal",
        "disease",
        "investor",
        "blockbuster",
        "wall",
        "street",
        "doubt",
        "muster",
        "food",
        "administration",
        "yearslong",
        "design",
        "judgment",
        "data",
        "agency",
        "second",
        "place",
        "application",
        "research",
        "al",
        "sandrock",
        "hypothesis",
        "theory",
        "protein",
        "form",
        "dementia",
        "today",
        "industry",
        "way",
        "eisais",
        "executive",
        "revival",
        "enrollment",
        "latestage",
        "midstage",
        "phase",
        "engage",
        "part",
        "futility",
        "half",
        "chance",
        "success",
        "line",
        "sharon",
        "director",
        "memory",
        "answer",
        "dud",
        "fact",
        "benefit",
        "contradiction",
        "failure",
        "time",
        "midjune",
        "budd",
        "haeberlein",
        "deal"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}